EA200601469A1 - Способ отделения промежуточных соединений, который может быть использован для получения эсциталопрама - Google Patents

Способ отделения промежуточных соединений, который может быть использован для получения эсциталопрама

Info

Publication number
EA200601469A1
EA200601469A1 EA200601469A EA200601469A EA200601469A1 EA 200601469 A1 EA200601469 A1 EA 200601469A1 EA 200601469 A EA200601469 A EA 200601469A EA 200601469 A EA200601469 A EA 200601469A EA 200601469 A1 EA200601469 A1 EA 200601469A1
Authority
EA
Eurasian Patent Office
Prior art keywords
separation
escital
prema
receiving
hydroxymethylbenzonitrile
Prior art date
Application number
EA200601469A
Other languages
English (en)
Other versions
EA012503B1 (ru
Inventor
Ларс Оле Люнгсе
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36603240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601469(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200601469A1 publication Critical patent/EA200601469A1/ru
Publication of EA012503B1 publication Critical patent/EA012503B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Изобретение связано со способом разделения и выделения ацилированного производного 4-[(S)-4-диметиламино-1-(4-фторфенил)-1-гидроксибутил]-3-гидроксиметилбензонитрила посредством взаимодействия смеси 4-[ (S)-4-диметиламино-1-(4-фторфенил)-1-гидроксибутил]-3-гидроксиметилбензонитрила и его ацилированного производного с соединением, которое образует производное 4-[(S)-4-диметиламино-1-(4-фторфенил)-1-гидроксибутил]-3-гидроксиметилбензонитрила, содержащее группу карбоновой кислоты. Ацилированное производное, содержащее группу карбоновой кислоты, выпадает в осадок сразу же после его образования и может быть легко отделено от реакционной смеси.
EA200601469A 2004-02-12 2005-02-02 Способ отделения промежуточных соединений, который может быть использован для получения эсциталопрама EA012503B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54497004P 2004-02-12 2004-02-12
DKPA200400217 2004-02-12
PCT/DK2005/000075 WO2005077891A1 (en) 2004-02-12 2005-02-02 Method for the separation of intermediates which may be used for the preparation of escitalopram

Publications (2)

Publication Number Publication Date
EA200601469A1 true EA200601469A1 (ru) 2006-12-29
EA012503B1 EA012503B1 (ru) 2009-10-30

Family

ID=36603240

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601469A EA012503B1 (ru) 2004-02-12 2005-02-02 Способ отделения промежуточных соединений, который может быть использован для получения эсциталопрама

Country Status (27)

Country Link
US (1) US7582780B2 (ru)
EP (1) EP1716108B1 (ru)
JP (1) JP4975450B2 (ru)
KR (1) KR101156495B1 (ru)
CN (1) CN1918112B (ru)
AR (1) AR047522A1 (ru)
AT (1) ATE411278T1 (ru)
AU (1) AU2005212455A1 (ru)
BR (1) BRPI0507580B8 (ru)
CA (1) CA2555980C (ru)
DK (1) DK1716108T3 (ru)
EA (1) EA012503B1 (ru)
ES (1) ES2315832T3 (ru)
HK (1) HK1100922A1 (ru)
IL (1) IL177365A0 (ru)
MY (1) MY144749A (ru)
NZ (1) NZ548441A (ru)
PE (1) PE20051139A1 (ru)
PL (1) PL1716108T3 (ru)
PT (1) PT1716108E (ru)
RS (1) RS50689B (ru)
SI (1) SI1716108T1 (ru)
TW (1) TWI339651B (ru)
UA (1) UA86403C2 (ru)
UY (1) UY28743A1 (ru)
WO (1) WO2005077891A1 (ru)
ZA (1) ZA200606639B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100548974C (zh) * 2007-10-11 2009-10-14 浙江大学 西酞普兰中间体的萃取分离方法
CN108640856B (zh) * 2018-06-11 2021-06-25 淮阴工学院 一种依地普仑中间体的不对称合成方法及其中间体

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
KR100411505B1 (ko) 1998-10-20 2003-12-18 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
ES2229774T3 (es) 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
CN1429219A (zh) 2000-03-13 2003-07-09 H·隆德贝克有限公司 制备西酞普兰的方法
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
ATE257832T1 (de) 2000-03-14 2004-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
TR200202168T2 (tr) 2000-03-16 2002-12-23 H. Lundbeck A/S 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
EA006213B1 (ru) * 2001-07-31 2005-10-27 Х. Лундбекк А/С Кристаллическая композиция, содержащая эсциталопрам
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
ES2194597B2 (es) * 2002-01-25 2004-08-01 Esteve Quimica, S.A. Procedimiento para la obtencion de citalopram.
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
CA2381341A1 (en) * 2002-04-09 2003-10-09 Torcan Chemical Ltd. Process and intermediates for preparing escitalopram
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
EP2363389A1 (en) * 2002-12-23 2011-09-07 H. Lundbeck A/S A process for the preparation of racemic citalopram diol and/or S- or R-citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram

Also Published As

Publication number Publication date
ZA200606639B (en) 2007-12-27
NZ548441A (en) 2009-12-24
EA012503B1 (ru) 2009-10-30
IL177365A0 (en) 2006-12-10
PT1716108E (pt) 2008-12-31
KR20060116222A (ko) 2006-11-14
JP4975450B2 (ja) 2012-07-11
SI1716108T1 (sl) 2009-02-28
DK1716108T3 (da) 2009-01-19
CN1918112B (zh) 2011-11-23
US7582780B2 (en) 2009-09-01
ES2315832T3 (es) 2009-04-01
EP1716108B1 (en) 2008-10-15
BRPI0507580B8 (pt) 2021-05-25
WO2005077891A1 (en) 2005-08-25
EP1716108A1 (en) 2006-11-02
ATE411278T1 (de) 2008-10-15
AR047522A1 (es) 2006-01-25
TWI339651B (en) 2011-04-01
US20070190624A1 (en) 2007-08-16
MY144749A (en) 2011-10-31
CN1918112A (zh) 2007-02-21
PL1716108T3 (pl) 2009-04-30
BRPI0507580A (pt) 2007-07-31
CA2555980C (en) 2010-08-03
TW200530210A (en) 2005-09-16
PE20051139A1 (es) 2006-01-28
HK1100922A1 (en) 2007-10-05
JP2007524678A (ja) 2007-08-30
CA2555980A1 (en) 2005-08-25
UY28743A1 (es) 2005-09-30
KR101156495B1 (ko) 2012-07-06
UA86403C2 (ru) 2009-04-27
BRPI0507580B1 (pt) 2018-01-09
RS50689B (sr) 2010-06-30
AU2005212455A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
CY1109760T1 (el) Παραγωγα ινδολης-3-θειου
WO2007127297A3 (en) Crystalline forms of a dimethylphenyl compound
NO20063501L (no) Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese
WO2006121558A3 (en) Method of prevention and treatment of aging, a related disorders and/or age-related manifestations includi r c erosis.
SE0303180D0 (sv) Novel compounds
NO20060544L (no) Enzymatiske prosesser for produksjon av 4-substituerte 3-hydroksysmorsyrederivater og naerliggende cyano, hydroksy substituerte karboksylsyre estere
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
EA200970051A1 (ru) Антагонист рецептора il-8
NO20064200L (no) Fremgangsmate for syntese av en CXCR4-antagonist
DK1831239T3 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde
MX2007009282A (es) Nuevos procesos para la preparacion de un 2h-cromeno.
EA201070589A1 (ru) Способ получения морфийных соединений
TW200639143A (en) A process for the distillation of a mixture of isomeric diisocyanatodiphenyl-methanes
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
WO2007054771A3 (en) An improved process for the preparation of cilastatin and sodium salt
EA200601469A1 (ru) Способ отделения промежуточных соединений, который может быть использован для получения эсциталопрама
NO20075829L (no) Syntese
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
MY150817A (en) Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
ATE437883T1 (de) Verfahren zur trennung von zirkonium und hafnium
HU0402465D0 (en) Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
WO2007080470A3 (en) A method for the purification of levetiracetam